Cargando…
Molecular and cellular mechanisms of castration resistant prostate cancer
With increases in the mortality rate and number of patients with prostate cancer (PCa), PCa, particularly the advanced and metastatic disease, has been the focus of a number of studies globally. Over the past seven decades, androgen deprivation therapy has been the primary therapeutic option for pat...
Autores principales: | Huang, Yiqiao, Jiang, Xianhan, Liang, Xue, Jiang, Ganggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876469/ https://www.ncbi.nlm.nih.gov/pubmed/29616091 http://dx.doi.org/10.3892/ol.2018.8123 |
Ejemplares similares
-
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer
por: Huang, Yiqiao, et al.
Publicado: (2018) -
p62 promotes proliferation, apoptosis-resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis
por: Jiang, Ganggang, et al.
Publicado: (2020) -
Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer
por: Lin, Yu, et al.
Publicado: (2023) -
Targeting molecular resistance in castration-resistant prostate cancer
por: Chandrasekar, Thenappan, et al.
Publicado: (2015) -
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
por: Chandrasekar, Thenappan, et al.
Publicado: (2015)